|
US4713249A
(en)
|
1981-11-12 |
1987-12-15 |
Schroeder Ulf |
Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
|
|
DE3376114D1
(en)
|
1982-12-07 |
1988-05-05 |
Kyowa Hakko Kogyo Kk |
Mitomycin analogues
|
|
JPS60255789A
(ja)
|
1984-06-01 |
1985-12-17 |
Kyowa Hakko Kogyo Co Ltd |
マイトマイシン誘導体，その製造法および抗腫瘍剤
|
|
US5266333A
(en)
|
1985-03-06 |
1993-11-30 |
American Cyanamid Company |
Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
|
|
WO1988001622A1
(fr)
|
1986-08-29 |
1988-03-10 |
Kyowa Hakko Kogyo Kabusiki Kaisha |
Derives de mitomycine
|
|
AU634314B2
(en)
|
1989-11-13 |
1993-02-18 |
Green Cross Corporation, The |
Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
|
|
US5627165A
(en)
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
|
AU653565B2
(en)
|
1990-12-21 |
1994-10-06 |
Nikken Corporation |
Raw sewage disposal apparatus and prefab for accomodating the same
|
|
US6291196B1
(en)
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US5674977A
(en)
|
1993-02-05 |
1997-10-07 |
The Ontario Cancer Institute |
Branched synthetic peptide conjugate
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
JP3538221B2
(ja)
|
1993-11-19 |
2004-06-14 |
富士写真フイルム株式会社 |
定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法
|
|
US5866679A
(en)
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
|
US6946133B1
(en)
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
AU726914B2
(en)
|
1996-04-01 |
2000-11-23 |
Epix Pharmaceuticals, Inc. |
Bioactivated diagnostic imaging contrast agents
|
|
JP2000508171A
(ja)
|
1996-04-05 |
2000-07-04 |
ザ・ジョンズ・ホプキンス・ユニバーシティ・スクール・オブ・メディシン |
希少細胞の富化方法
|
|
US5795877A
(en)
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
|
US5672592A
(en)
|
1996-06-17 |
1997-09-30 |
Guilford Pharmaceuticals Inc. |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
|
|
US6054444A
(en)
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
|
US5902817A
(en)
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
|
US5863536A
(en)
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
|
US5998362A
(en)
|
1996-09-12 |
1999-12-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US5962521A
(en)
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
|
US6177404B1
(en)
|
1996-10-15 |
2001-01-23 |
Merck & Co., Inc. |
Conjugates useful in the treatment of benign prostatic hyperplasia
|
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US7008765B1
(en)
|
1997-04-10 |
2006-03-07 |
The Johns Hopkins University |
PCA3, PCA3 genes, and methods of use
|
|
US6127333A
(en)
|
1997-07-10 |
2000-10-03 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US20020115596A1
(en)
|
1997-10-27 |
2002-08-22 |
Merk & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
ZA9810974B
(en)
|
1997-12-02 |
1999-06-03 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
|
US20040081659A1
(en)
|
1997-12-02 |
2004-04-29 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
IL136167A0
(en)
|
1997-12-02 |
2001-05-20 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
|
WO1999045374A2
(en)
|
1998-03-03 |
1999-09-10 |
Mosaic Technologies |
Purification and detection processes using reversible affinity electrophoresis
|
|
US20020103136A1
(en)
|
1998-03-05 |
2002-08-01 |
Dong-Mei Feng |
Conjugates useful in the treatment of prostate cancer
|
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
|
ATE437947T1
(de)
|
1998-06-01 |
2009-08-15 |
Agensys Inc |
Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
|
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20070020327A1
(en)
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
|
US6174858B1
(en)
|
1998-11-17 |
2001-01-16 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
WO2000059930A1
(en)
|
1999-04-05 |
2000-10-12 |
Merck & Co., Inc. |
A method of treating cancer
|
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
|
CA2367787C
(en)
|
1999-04-28 |
2011-07-26 |
Alan P. Kozikowski |
Ligands for metabotropic glutamate receptors
|
|
AUPQ014799A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using polymers
|
|
US7166573B1
(en)
|
1999-05-28 |
2007-01-23 |
Ludwig Institute For Cancer Research |
Breast, gastric and prostate cancer associated antigens and uses therefor
|
|
US20040146516A1
(en)
|
1999-06-17 |
2004-07-29 |
Utah Ventures Ii L.P. |
Lumen-exposed molecules and methods for targeted delivery
|
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US6428785B1
(en)
|
1999-10-28 |
2002-08-06 |
Immunolytics Inc. |
Method and composition for treating prostate cancer
|
|
CA2391534A1
(en)
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Selective cellular targeting: multifunctional delivery vehicles
|
|
US7033594B2
(en)
|
2000-03-31 |
2006-04-25 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
AU2440102A
(en)
|
2000-10-16 |
2002-04-29 |
Gilead Sciences Inc |
Nucleic acid ligands to the prostate specific membrane antigen
|
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
US7468354B2
(en)
|
2000-12-01 |
2008-12-23 |
Genspera, Inc. |
Tissue specific prodrugs
|
|
AU2002249935A1
(en)
|
2001-01-08 |
2002-08-19 |
Neorx Corporation |
Radioactively labelled conjugates of phosphonates
|
|
MXPA03007037A
(es)
|
2001-02-07 |
2003-11-18 |
Beth Israel Hospital |
Ligandos del antigeno de membrana especifico de prostata (amep) y usos relacionados del mismo.
|
|
AU2002306766A1
(en)
|
2001-03-16 |
2002-10-03 |
Johns Hopkins University School Of Medicine |
Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
|
|
EP1389209B1
(en)
|
2001-04-24 |
2009-04-08 |
Purdue Research Foundation |
Folate mimetics and folate-receptor binding conjugates thereof
|
|
NZ529808A
(en)
|
2001-05-02 |
2007-02-23 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US7109165B2
(en)
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
EP1392360B1
(en)
|
2001-06-01 |
2011-11-30 |
Cornell Research Foundation, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
US20040018203A1
(en)
|
2001-06-08 |
2004-01-29 |
Ira Pastan |
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
|
|
EP1410022B1
(en)
|
2001-06-21 |
2009-05-06 |
GlycoMimetics, Inc. |
Detection and treatment of prostate cancer
|
|
US20030031677A1
(en)
|
2001-06-25 |
2003-02-13 |
Drug Innovation & Design, Incorporated |
Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications
|
|
US7893223B2
(en)
*
|
2001-07-17 |
2011-02-22 |
Bracco Imaging S.P.A. |
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
|
|
US7282476B2
(en)
|
2001-08-24 |
2007-10-16 |
University Of Victoria Innovation And Development Corporation |
Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
|
|
IL159422A0
(en)
|
2001-09-20 |
2004-06-01 |
Cornell Res Foundation Inc |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
|
|
US20030232760A1
(en)
|
2001-09-21 |
2003-12-18 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
|
CA2461877A1
(en)
|
2001-09-28 |
2003-04-10 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
US20030215456A1
(en)
|
2001-10-02 |
2003-11-20 |
Sui-Long Yao |
Method of treating cancer
|
|
US20030133927A1
(en)
|
2001-10-10 |
2003-07-17 |
Defeo-Jones Deborah |
Conjugates useful in the treatment of prostate cancer
|
|
US20040058857A1
(en)
|
2001-11-29 |
2004-03-25 |
Siu-Long Yao |
Method of treating cancer
|
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
|
SI1472541T1
(sl)
|
2002-01-10 |
2010-12-31 |
Univ Johns Hopkins |
Prikazovalni agensi in postopek prikazovanja naaladase ali psma
|
|
WO2003074450A2
(en)
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
WO2003076593A2
(en)
|
2002-03-07 |
2003-09-18 |
The Johns Hopkins University School Of Medicine |
Genomic screen for epigenetically silenced genes associated with cancer
|
|
US7534580B2
(en)
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
|
EP2260875B1
(en)
|
2002-05-06 |
2014-04-23 |
Endocyte, Inc. |
Folate-receptor targeted imaging agents
|
|
ES2324708T3
(es)
|
2002-05-15 |
2009-08-13 |
Endocyte, Inc. |
Conjugados de vitamina-mitomicina.
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
EP1523493B1
(de)
|
2002-07-09 |
2013-09-04 |
Dömling, Alexander |
Neue tubulysinanaloga
|
|
AR040956A1
(es)
|
2002-07-31 |
2005-04-27 |
Schering Ag |
Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
US7749968B2
(en)
|
2002-08-05 |
2010-07-06 |
The Johns Hopkins University |
Peptides for targeting the prostate specific membrane antigen
|
|
AU2003259761A1
(en)
|
2002-08-08 |
2004-02-25 |
Johns Hopkins University |
Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
|
|
DE10254439A1
(de)
|
2002-11-21 |
2004-06-03 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Tubulysine, Herstellungsverfahren und Tubulysin-Mittel
|
|
US8487128B2
(en)
|
2002-11-26 |
2013-07-16 |
Chs Pharma, Inc. |
Protection of normal cells
|
|
US7875586B2
(en)
|
2002-12-20 |
2011-01-25 |
The Johns Hopkins University |
Treatment of metastatic colon cancer with b-subunit of shiga toxin
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
US20080008649A1
(en)
|
2003-01-13 |
2008-01-10 |
Bracco Imaging S.P.A. |
Gastrin Releasing Peptide Compounds
|
|
TWI367096B
(en)
|
2003-01-27 |
2012-07-01 |
Endocyte Inc |
Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions
|
|
WO2004067570A2
(en)
|
2003-01-28 |
2004-08-12 |
Proscan Rx Pharma |
Prostate cancer diagnosis and treatment
|
|
EP1444990A1
(en)
|
2003-02-07 |
2004-08-11 |
Amersham plc |
Improved Radiometal Complex Compositions
|
|
US7638122B2
(en)
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
EP1603392A2
(en)
|
2003-03-07 |
2005-12-14 |
The University Of Toledo |
Paclitaxel hybrid derivatives
|
|
US20070179100A1
(en)
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
|
EP2660322A3
(en)
|
2003-04-17 |
2013-11-13 |
Alnylam Pharmaceuticals Inc. |
Modified iRNA agents
|
|
EP1641742A4
(en)
|
2003-05-01 |
2006-11-29 |
Nst Neurosurvival Technologies |
COMPOUNDS BINDING SELECTIVELY TO MEMBRANES OF APOPTOTIC CELLS
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
WO2005021494A2
(en)
|
2003-06-13 |
2005-03-10 |
Immunomedics, Inc. |
D-amino acid peptides
|
|
US7232805B2
(en)
*
|
2003-09-10 |
2007-06-19 |
Inflabloc Pharmaceuticals, Inc. |
Cobalamin conjugates for anti-tumor therapy
|
|
US20050255042A1
(en)
|
2003-11-24 |
2005-11-17 |
The Regents Of The University Of California Office Of Technology Transfer, University Of California |
On-demand cleavable linkers for radioconjugates for cancer imaging and therapy
|
|
FR2864546A1
(fr)
|
2003-12-24 |
2005-07-01 |
Assist Publ Hopitaux De Paris |
Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
|
|
WO2007010534A2
(en)
|
2005-07-19 |
2007-01-25 |
Spectrum Dynamics Llc |
Imaging protocols
|
|
US8586932B2
(en)
|
2004-11-09 |
2013-11-19 |
Spectrum Dynamics Llc |
System and method for radioactive emission measurement
|
|
DE102004004787A1
(de)
|
2004-01-30 |
2005-08-18 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
WO2005094882A1
(en)
|
2004-03-03 |
2005-10-13 |
Millennium Pharmaceuticals, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
CN1926433A
(zh)
|
2004-03-03 |
2007-03-07 |
拜奥默里克斯公司 |
用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途
|
|
ES2311895T3
(es)
|
2004-03-15 |
2009-02-16 |
F. Hoffmann-La Roche Ag |
El uso de los peptidos tipo bnp y de los peptidos tipo anf para evaluar el riesgo de padecer una complicacion cardio-vascular como frecuencia de sobrecarga del volumen.
|
|
EP1737879B1
(en)
|
2004-04-19 |
2012-10-10 |
Archemix LLC |
Aptamer-mediated intracellular delivery of therapeutic oligonucleotides
|
|
CA2606138A1
(en)
|
2004-04-19 |
2005-10-27 |
Proscan Rx Pharma |
Prostate cancer diagnosis and treatment
|
|
RU2402548C2
(ru)
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
|
CN101098854B
(zh)
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
CA2573192C
(en)
|
2004-08-04 |
2013-09-10 |
Applied Molecular Evolution Inc. |
Variant fc regions
|
|
WO2006024160A1
(en)
|
2004-08-30 |
2006-03-09 |
Neuromed Pharmaceuticals Ltd. |
Urea derivatives as calcium channel blockers
|
|
US7713944B2
(en)
|
2004-10-13 |
2010-05-11 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
|
|
WO2006049891A1
(en)
|
2004-10-27 |
2006-05-11 |
Janssen Pharmaceutica N.V. |
Trisubstituted thiophenes as progesterone receptor modulators
|
|
US8000773B2
(en)
|
2004-11-09 |
2011-08-16 |
Spectrum Dynamics Llc |
Radioimaging
|
|
EP1827505A4
(en)
|
2004-11-09 |
2017-07-12 |
Biosensors International Group, Ltd. |
Radioimaging
|
|
US20060140871A1
(en)
|
2004-11-30 |
2006-06-29 |
Sillerud Laurel O |
Magnetic resonance imaging of prostate cancer
|
|
EP1844351A4
(en)
|
2005-01-13 |
2017-07-05 |
Biosensors International Group, Ltd. |
Multi-dimensional image reconstruction and analysis for expert-system diagnosis
|
|
US7741510B2
(en)
|
2005-01-13 |
2010-06-22 |
E. I. Du Pont De Nemours And Company |
Rheology control agents
|
|
US20060155021A1
(en)
|
2005-01-13 |
2006-07-13 |
Lenges Christian P |
Coating compositions containing rheology control agents
|
|
EP1846576A4
(en)
|
2005-02-01 |
2009-01-07 |
Us Gov Health & Human Serv |
BIOMARKERS OF TISSUE STATUS
|
|
WO2006093991A1
(en)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Compounds which bind psma and uses thereof
|
|
CA2600418A1
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
KR101068612B1
(ko)
|
2005-05-24 |
2011-09-30 |
휴마시스 주식회사 |
유사구조 단백질 비율 측정을 이용한 진단장치
|
|
BRPI0612529A2
(pt)
|
2005-06-20 |
2010-11-23 |
Psma Dev Company Llc |
conjugados de anticorpo-medicamento de psma
|
|
JP5175723B2
(ja)
|
2005-07-05 |
2013-04-03 |
パーデュー・リサーチ・ファウンデーション |
単球介在性疾患を治療するための組成物の調製
|
|
US20070010014A1
(en)
|
2005-07-06 |
2007-01-11 |
General Electric Company |
Compositions and methods for enhanced delivery to target sites
|
|
CA2617660C
(en)
|
2005-08-19 |
2014-03-25 |
Endocyte, Inc. |
Multi-drug ligand conjugates
|
|
US20100144641A1
(en)
|
2005-09-12 |
2010-06-10 |
Popel Aleksander S |
Compositions Having Antiangiogenic Activity and Uses Thereof
|
|
CA2625196C
(fr)
|
2005-10-07 |
2016-04-05 |
Guerbet |
Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
|
|
JP2009518289A
(ja)
|
2005-11-21 |
2009-05-07 |
メディバス エルエルシー |
高分子の送達用ポリマー粒子および使用方法
|
|
ES2804129T3
(es)
|
2005-11-23 |
2021-02-03 |
Ventana Med Syst Inc |
Conjugado anticuerpo-enzima
|
|
WO2007081751A2
(en)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
US7635682B2
(en)
|
2006-01-06 |
2009-12-22 |
Genspera, Inc. |
Tumor activated prodrugs
|
|
WO2007106869A1
(en)
|
2006-03-14 |
2007-09-20 |
Cancer Targeted Technology Llc |
Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use
|
|
US8940871B2
(en)
|
2006-03-20 |
2015-01-27 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
US20140314864A1
(en)
|
2006-03-31 |
2014-10-23 |
Massachusetts Institute Of Technology |
System for Targeted Delivery of Therapeutic Agents
|
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
NZ574887A
(en)
*
|
2006-07-31 |
2012-02-24 |
Bayer Consumer Care Ag |
An assembly for location at an receptacle opening comprising an insert with a cutter coupled to an actuator
|
|
CA2668197A1
(en)
|
2006-11-03 |
2008-05-15 |
Philip S. Low |
Ex vivo flow cytometry method and device
|
|
BRPI0718700B8
(pt)
|
2006-11-08 |
2023-11-07 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutâmico, e kit
|
|
JP2010511713A
(ja)
|
2006-12-05 |
2010-04-15 |
ランデック コーポレイション |
薬物送達
|
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
CN103372221B
(zh)
|
2007-01-11 |
2016-08-24 |
免疫医学股份有限公司 |
用于蛋白质、肽和其他分子的改进的f-18标记的方法和组合物
|
|
EP2125855A4
(en)
|
2007-01-26 |
2013-03-27 |
Hope City |
METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
|
|
US8586595B2
(en)
|
2007-02-07 |
2013-11-19 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
AU2008224988A1
(en)
*
|
2007-03-14 |
2008-09-18 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
EP2136788B1
(en)
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Cancer cell targeting using nanoparticles
|
|
WO2008124197A1
(en)
|
2007-04-10 |
2008-10-16 |
The Johns Hopkins University |
Imaging and therapy of virus-associated tumors
|
|
EP3569251A1
(en)
|
2007-06-25 |
2019-11-20 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
CN104774175B
(zh)
|
2007-06-26 |
2019-04-16 |
约翰·霍普金斯大学 |
标记的前列腺特异性膜抗原(psma)的抑制子、生物学评估及作为成像试剂的用途
|
|
GB0723246D0
(en)
|
2007-07-03 |
2008-01-09 |
Barton Michelle |
p53 modulator
|
|
EP2514762B1
(en)
|
2007-07-13 |
2015-04-08 |
The Johns Hopkins University |
B7-DC variants
|
|
WO2009018500A1
(en)
|
2007-07-31 |
2009-02-05 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
WO2009026177A1
(en)
|
2007-08-17 |
2009-02-26 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2009035942A1
(en)
|
2007-09-13 |
2009-03-19 |
Chemimage Corporation |
Distinguishing between renal oncocytoma and chromophobe renal cell carcinoma using raman molecular imaging
|
|
CN101909441B
(zh)
|
2007-10-25 |
2015-05-13 |
恩多塞特公司 |
微管蛋白抑制剂及其制备方法
|
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
|
WO2009070302A1
(en)
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
|
AU2008340354B2
(en)
|
2007-12-04 |
2014-04-17 |
Alnylam Pharmaceuticals, Inc. |
Folate-iRNA conjugates
|
|
US20090180951A1
(en)
|
2007-12-12 |
2009-07-16 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
|
EP2240171B1
(en)
|
2008-01-09 |
2014-08-13 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of carbonic anhydrase IX
|
|
US8562945B2
(en)
|
2008-01-09 |
2013-10-22 |
Molecular Insight Pharmaceuticals, Inc. |
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
US8852630B2
(en)
|
2008-05-13 |
2014-10-07 |
Yale University |
Chimeric small molecules for the recruitment of antibodies to cancer cells
|
|
DK2291659T3
(en)
|
2008-05-13 |
2015-12-21 |
Univ Yale |
SMALL CHEMICAL MOLECULES FOR RECRUITING ANTIBODIES TO CANCER CELLS
|
|
EP2309990B2
(en)
|
2008-06-16 |
2017-03-15 |
Pfizer Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
RU2494096C2
(ru)
*
|
2008-08-01 |
2013-09-27 |
Дзе Джонс Хопкинс Юниверсити |
Агенты, связывающиеся с psma, и их применение
|
|
AU2009281732A1
(en)
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
EP2727606A3
(en)
|
2008-09-08 |
2015-09-23 |
Psma Development Company, L.L.C. |
Compounds for killing psma-expressing, taxane-resistant cancer cells
|
|
EP2166021A1
(en)
|
2008-09-16 |
2010-03-24 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies for treatment of cancer
|
|
NZ592255A
(en)
|
2008-09-17 |
2013-07-26 |
Endocyte Inc |
Folate receptor binding conjugates of antifolates
|
|
US20110288152A1
(en)
|
2008-10-17 |
2011-11-24 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2010065906A2
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
|
|
CA2745958A1
(en)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
|
|
EP3495000A1
(en)
|
2009-02-17 |
2019-06-12 |
Cornell Research Foundation, Inc. |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
EP2408465A4
(en)
|
2009-03-17 |
2012-11-28 |
Univ Johns Hopkins |
METHODS AND COMPOSITIONS FOR CANCER SCREENING
|
|
CA3131469A1
(en)
|
2009-03-19 |
2010-09-23 |
The Johns Hopkins University |
Psma-targeting compounds and uses thereof
|
|
BR112012000210A2
(pt)
|
2009-06-15 |
2019-09-24 |
Molecular Insight Pharm Inc |
processo para a produção de heterodímeoros de ácido glutâmico.
|
|
CN104857534A
(zh)
|
2009-07-31 |
2015-08-26 |
恩多塞特公司 |
叶酸盐靶向的诊断和治疗
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
WO2011031517A1
(en)
|
2009-08-27 |
2011-03-17 |
Nuclea Biotechnologies, LLC |
Method and assay for determining fas expression
|
|
MX337600B
(es)
|
2009-12-02 |
2016-03-11 |
Imaginab Inc |
Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antigeno de membrana especifico para prostata de humano (psma) y metodos para su uso.
|
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
|
JP5964756B2
(ja)
|
2010-02-04 |
2016-08-03 |
ラジウス ヘルス，インコーポレイテッド |
選択的アンドロゲン受容体モジュレーター
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CA2790577A1
(en)
|
2010-02-25 |
2011-09-01 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
CN101863924B
(zh)
|
2010-05-17 |
2012-06-27 |
北京师范大学 |
99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法
|
|
CN103140227B
(zh)
|
2010-08-06 |
2016-01-20 |
恩多塞特公司 |
制备微管蛋白细胞溶素的方法
|
|
KR101236142B1
(ko)
|
2010-09-30 |
2013-02-21 |
경북대학교 산학협력단 |
가돌리늄 착물을 함유하는 ｍｒｉ조영제
|
|
EP2648766B1
(en)
|
2010-12-06 |
2018-04-18 |
Molecular Insight Pharmaceuticals, Inc. |
Psma-targeted dendrimers
|
|
US20140308363A1
(en)
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
TR201910084T4
(tr)
|
2011-08-05 |
2019-08-21 |
Molecular Insight Pharm Inc |
Radyoaktif-etiketli prostat spesifik membran antijen inhibitörleri.
|
|
US10011632B2
(en)
|
2011-08-22 |
2018-07-03 |
Siemens Medical Solutions Usa, Inc. |
PSMA imaging agents
|
|
WO2013130776A1
(en)
|
2012-02-29 |
2013-09-06 |
Purdue Research Foundation |
Folate receptor alpha binding ligands
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
US20140107316A1
(en)
|
2012-10-16 |
2014-04-17 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
MX2015004757A
(es)
|
2012-10-16 |
2015-07-17 |
Endocyte Inc |
Conjugados de suministro de farmacos que contienen aminoacidos no naturales y metodo para usarlos.
|
|
EP2919774A4
(en)
|
2012-11-15 |
2016-11-09 |
Endocyte Inc |
CONJUGATES FOR THE TREATMENT OF DISEASES CAUSED BY PSMA-EXPRESSING CELLS
|
|
US20140154702A1
(en)
|
2012-11-30 |
2014-06-05 |
Endocyte, Inc. |
Methods For Treating Cancer Using Combination Therapies
|
|
AU2013366490B9
(en)
|
2012-12-21 |
2018-02-01 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
AU2013369982B2
(en)
|
2012-12-28 |
2016-11-17 |
Tva (Abc), Llc |
Targeted conjugates encapsulated in particles and formulations thereof
|
|
US9889199B2
(en)
|
2013-02-15 |
2018-02-13 |
Case Western Reserve University |
PSMA ligands and uses thereof
|
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
|
US10406246B2
(en)
|
2013-10-17 |
2019-09-10 |
Deutsches Kresbsforschungszentrum |
Double-labeled probe for molecular imaging and use thereof
|
|
US20150110814A1
(en)
|
2013-10-18 |
2015-04-23 |
Psma Development Company, Llc |
Combination therapies with psma ligand conjugates
|
|
EP4374924A3
(en)
|
2013-10-18 |
2024-08-07 |
Novartis AG |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
SG10201803618RA
(en)
|
2013-11-14 |
2018-06-28 |
Endocyte Inc |
Compounds for positron emission tomography
|
|
CN106660943B
(zh)
|
2014-05-06 |
2020-03-17 |
约翰霍普金斯大学 |
用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物
|
|
EP2993171A1
(en)
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18F-labeled PSMA-specific PET-tracers
|
|
WO2016030329A1
(en)
|
2014-08-24 |
2016-03-03 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
|
|
AU2015315465B2
(en)
|
2014-09-08 |
2019-08-29 |
Molecular Insight Pharmaceuticals, Inc. |
Organ protection in PSMA-targeted radionuclide therapy of prostate cancer
|
|
EP3853213A4
(en)
*
|
2018-09-21 |
2022-07-06 |
Endocyte, Inc. |
Shielding agents and their use
|